Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparison of 2 thrombus aspiration devices with histopathological analysis of retrieved material in patients presenting with ST-segment elevation myocardial infarction.
Vlaar PJ, Svilaas T, Vogelzang M, Diercks GF, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan E, Suurmeijer AJ, Zijlstra F. Vlaar PJ, et al. Among authors: de smet bj. JACC Cardiovasc Interv. 2008 Jun;1(3):258-64. doi: 10.1016/j.jcin.2008.03.014. JACC Cardiovasc Interv. 2008. PMID: 19463309 Free article. Clinical Trial.
Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
Fokkema ML, Vlaar PJ, Vogelzang M, Gu YL, Kampinga MA, de Smet BJ, Jessurun GA, Anthonio RL, van den Heuvel AF, Tan ES, Zijlstra F. Fokkema ML, et al. Among authors: de smet bj. Circ Cardiovasc Interv. 2009 Aug;2(4):323-9. doi: 10.1161/CIRCINTERVENTIONS.109.858977.109.858977. Epub 2009 Jul 22. Circ Cardiovasc Interv. 2009. PMID: 20031735 Clinical Trial.
Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
Lexis CP, van der Horst IC, Lipsic E, van der Harst P, van der Horst-Schrivers AN, Wolffenbuttel BH, de Boer RA, van Rossum AC, van Veldhuisen DJ, de Smet BJ; GIPS-III Investigators. Lexis CP, et al. Among authors: de boer ra, de smet bj. Cardiovasc Drugs Ther. 2012 Oct;26(5):417-26. doi: 10.1007/s10557-012-6413-1. Cardiovasc Drugs Ther. 2012. PMID: 22968678 Free PMC article. Clinical Trial.
Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Fokkema ML, James SK, Albertsson P, Aasa M, Åkerblom A, Calais F, Eriksson P, Jensen J, Schersten F, de Smet BJ, Sjögren I, Tornvall P, Lagerqvist B. Fokkema ML, et al. Among authors: de smet bj. EuroIntervention. 2016 Jun 20;12(3):303-11. doi: 10.4244/EIJY15M10_07. EuroIntervention. 2016. PMID: 26485732 Free article.
Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
Fokkema ML, James SK, Albertsson P, Akerblom A, Calais F, Eriksson P, Jensen J, Nilsson T, de Smet BJ, Sjögren I, Thorvinger B, Lagerqvist B. Fokkema ML, et al. Among authors: de smet bj. J Am Coll Cardiol. 2013 Mar 26;61(12):1222-30. doi: 10.1016/j.jacc.2013.01.007. J Am Coll Cardiol. 2013. PMID: 23500325 Free article.
73 results